Last Updated:
Access Report
Name Designation Appointment Date Status
Dheeraj Kumar Arora

Appointed as Additional Director since August 2011

 Additional Director 19-Aug-2011 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Gopi Nath Sahu

Appointed as Director since December 2009

 Director 15-Dec-2009 Current
Nidhi Sharma

Appointed as Additional Director since August 2010

 Additional Director 03-Aug-2010 Current

People Timeline

Explore the timeline of key personnel in Corwis Pharmaceuticals Limited's leadership journey.

Contact Details
  • Address 201, Mohan Place, Lsc Block-C, Saraswati Vihar, Delhi Delhi, 110034, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 110034
  • Country India
  • Website -
Frequently Asked Questions
How can I contact Corwis Pharmaceuticals Limited?
You can contact Corwis Pharmaceuticals Limited through their registered address at 201, Mohan Place, Lsc Block-C, Saraswati Vihar, Delhi Delhi, 110034, India, or via their website if available. Social media links are also provided where applicable.
Who are the current directors of Corwis Pharmaceuticals Limited?
The current directors of Corwis Pharmaceuticals Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • DHEERAJ KUMAR ARORA
  • GOPI NATH SAHU
  • NIDHI SHARMA
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available